Grant: Operating Grant
McGill University
$263,950.00
Assessing Time-Varying Drug Exposures in the Canadian Co-infection Cohort: Methodological Tools to Address Missing Data and Measurement Error
EF 2012-13
Résumé
Epidemiologic studies typically aim to estimate the true (causal) effect of an exposure such as medication or treatment on outcome, and cohort studies are often seen as an ideal way to investigate a range of outcomes - particularly time-to-event outcomes - due to the prospective nature of the follow-up. However, methodological challenges can arise in cohort studies where participants are recruited after disease onset, and so participants may have been exposed to risk factors of interest prior to cohort entry. It is also sometimes the case that affected individuals who experience an outcome of interest such as death may not survive long enough to enter the cohort, and that the time of cohort entry is not a clinically meaningful time origin. Furthermore, it is often the case that exposures of interest are not randomized, but rather their receipt is controlled by cohort participants and therefore the exposure level may be confounded by participant characteristics such as general level of health, socioeconomic status, and lifestyle or behavioural choices. Hence estimates from analyses of the response modeled as a function of received treatment based on the observed data only are often prone to bias.
Our projects are aimed at developing new methodological tools that will simultaneously address the three challenges noted above, thereby eliminating bias due to (i) cohort entry after both disease onset and after receipt of the exposure of interest, (ii) the non-random nature of the exposure, and (iii) measurement error so as to study questions of treatment and behavioural risk factors in an HIV-Hepatitis C co-infected population. In particular, we will investigate the effects of anti-retroviral treatment interruptions, illegal drug use, and alcohol consumption on liver fibrosis and end-stage liver disease.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
279414
Name
Moodie Erica E
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Public, Community & Population Health
Projecttitle
Assessing Time-Varying Drug Exposures in the Canadian Co-infection Cohort: Methodological Tools to Address Missing Data and Measurement Error
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$263,950
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biostatistics; Causal Inference; Epidemiology; Hepatitis C; Hiv; Methodology
Abstract
Epidemiologic studies typically aim to estimate the true (causal) effect of an exposure such as medication or treatment on outcome, and cohort studies are often seen as an ideal way to investigate a range of outcomes - particularly time-to-event outcomes - due to the prospective nature of the follow-up. However, methodological challenges can arise in cohort studies where participants are recruited after disease onset, and so participants may have been exposed to risk factors of interest prior to cohort entry. It is also sometimes the case that affected individuals who experience an outcome of interest such as death may not survive long enough to enter the cohort, and that the time of cohort entry is not a clinically meaningful time origin. Furthermore, it is often the case that exposures of interest are not randomized, but rather their receipt is controlled by cohort participants and therefore the exposure level may be confounded by participant characteristics such as general level of health, socioeconomic status, and lifestyle or behavioural choices. Hence estimates from analyses of the response modeled as a function of received treatment based on the observed data only are often prone to bias.
Our projects are aimed at developing new methodological tools that will simultaneously address the three challenges noted above, thereby eliminating bias due to (i) cohort entry after both disease onset and after receipt of the exposure of interest, (ii) the non-random nature of the exposure, and (iii) measurement error so as to study questions of treatment and behavioural risk factors in an HIV-Hepatitis C co-infected population. In particular, we will investigate the effects of anti-retroviral treatment interruptions, illegal drug use, and alcohol consumption on liver fibrosis and end-stage liver disease.
Competitiondate
201303
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Moodie, Erica E
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $263,950~ $0~